Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and Meningitis, Cryptococcal

voriconazole has been researched along with Meningitis, Cryptococcal in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (31.03)29.6817
2010's16 (55.17)24.3611
2020's4 (13.79)2.80

Authors

AuthorsStudies
Bocanegra, R; Graybill, JR; Kirkpatrick, WR; Najvar, LK; Patterson, TF1
Fang, T; Jiang, Y; Li, WP; Lin, Q; Peng, FH; Su, XH; Zheng, XJ1
Jiang, Y; Li, M; Liu, J; Peng, F; Su, X; Wang, A; Wang, Y; Xu, X; Yang, L1
Chen, Y; Harypursat, V; Lan, K; Lu, Y; Wu, Y; Xu, X; Yang, T; Yu, J; Zeng, Q; Zhang, W; Zhao, T; Zhou, G1
Guan, Y; Song, QL1
Aquino, VR; de Azevedo, MI; Goldani, LZ; Neto, GW; Pilla, C; Wirth, F1
Fica, A; Leiva Hernández, M; Salgueiro C, C; Téllez R, M1
Gao, T; Huang, XS; Tian, CL; Xing, XW; Yan, B; Yao, Y; Yu, SY; Zhang, JT1
Animalu, C; Cleveland, KO; Gelfand, MS; Mazumder, S1
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W1
Li, SS; Lu, MQ; Ni, SL; Tang, XY; Yang, NB; Zhang, SG1
Cervera, C; Crespo, G; Marco, F; Michelena, J; Moreno, A; Navasa, M1
dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I1
Guggemos, W; Hecht, A; Rüdisser, K; Seilmaier, M1
Bandettini, R; Calvillo, M; Castagnola, E; Conte, M; Cuzzubbo, D; Faraci, M; Lanino, E; Manzitti, C; Miano, M; Micalizzi, C; Morreale, G; Pescetto, L; Ravegnani, M; Ricagni, L; Soro, O1
Carbonara, S; Ciracì, E; Cusato, M; Heichen, M; Monno, L; Regazzi, M; Stano, F; Villani, P1
Chang, CM; Chang, HH; Ko, WC; Lee, HC; Lee, NY; Wu, CJ; Yang, YH1
Atienzar, M; Blanch, JJ; Escribano, E; Rodríguez, M1
Hogan, BK; Lewis, JS; Nierenberg, NE; Patterson, TF; Thompson, GR1
Fujishima, K; Fukae, J; Furuya, T; Hattori, N; Hirayama, T; Noda, K; Ogaki, K; Okuma, Y1
Yong, L1
Capilla, J; Gazzoni, AF; Guarro, J; Mayayo, E1
Niki, Y; Ohbayashi, H; Shoji, H; Takuma, T; Yamamoto, T; Yoshida, K1
Harada, H; Inoue, A; Iwata, S; Kumon, Y; Ohnishi, T; Teraoka, M; Yamashita, D1
Gamaletsou, MN; Kontos, AN; Kontoyiannis, DP; Kordossis, T; Sipsas, NV; Stefanou, I; Tsiakalos, A1
Baršić, B; Mlinarić Missoni, E1
Chiodo, F; Consales, A; Manfredi, R; Pavoni, M; Sabbatani, S1
Lu, HZ; Shen, YZ; Wang, JR1
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A1

Other Studies

29 other study(ies) available for voriconazole and Meningitis, Cryptococcal

ArticleYear
New guinea pig model of Cryptococcal meningitis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Animals; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Guinea Pigs; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole

2007
Case report: a special case of cryptococcal infection-related inflammatory syndrome in a non-HIV infected and non-transplant patient.
    BMC neurology, 2022, Jul-06, Volume: 22, Issue:1

    Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Syndrome; Voriconazole

2022
Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.
    BMC neurology, 2022, Jul-22, Volume: 22, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Hypokalemia; Meningitis, Cryptococcal; Retrospective Studies; Treatment Outcome; Voriconazole

2022
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
    BMC infectious diseases, 2022, Aug-08, Volume: 22, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Infertility; Meningitis, Cryptococcal; Prospective Studies; Voriconazole

2022
A case of acute pancreatitis induced by voriconazole during treatment of cryptococcal meningitis.
    British journal of clinical pharmacology, 2022, Volume: 88, Issue:4

    Topics: Acute Disease; Adolescent; Child; Female; Humans; Meningitis, Cryptococcal; Pancreas; Pancreatitis; Voriconazole

2022
Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
    Medical mycology, 2018, Apr-01, Volume: 56, Issue:3

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Child; Cryptococcus; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Follow-Up Studies; Humans; Intracranial Pressure; Male; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Tertiary Care Centers; Treatment Outcome; Voriconazole

2018
[Cerebral cryptococcosis and immune reconstitution inflammatory syndrome. Case report].
    Revista medica de Chile, 2018, Volume: 146, Issue:12

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Meningitis, Cryptococcal; Middle Aged; Voriconazole

2018
Voriconazole: a novel treatment option for cryptococcal meningitis.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:10

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Carbon; China; Cryptococcus neoformans; Diagnostic Errors; Drug Therapy, Combination; Female; Fluconazole; Humans; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers; Time Factors; Voriconazole

2015
Cryptococcus uniguttulatus Meningitis.
    The American journal of the medical sciences, 2015, Volume: 350, Issue:5

    Topics: Administration, Intravenous; Aged; Amphotericin B; Antifungal Agents; Cryptococcus; Drug Substitution; Female; Fluconazole; Glucocorticoids; Humans; Immunocompromised Host; Meningitis, Cryptococcal; Spinal Puncture; Treatment Outcome; Voriconazole

2015
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
    Mycoses, 2016, Volume: 59, Issue:6

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
Voriconazole combined with low-dose amphotericin B liposome for treatment of cryptococcal meningitis.
    Infectious diseases (London, England), 2016, Volume: 48, Issue:7

    Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Humans; Male; Meningitis, Cryptococcal; Voriconazole

2016
Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008, Volume: 14, Issue:11

    Topics: Adrenal Cortex Hormones; Anti-Retroviral Agents; Antifungal Agents; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Immune System; Inflammation; Liver Transplantation; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Recurrence; Triazoles; Voriconazole

2008
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
    Revista iberoamericana de micologia, 2008, Dec-31, Volume: 25, Issue:4

    Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2008
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
    Medizinische Klinik (Munich, Germany : 1983), 2009, Jan-15, Volume: 104, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Recurrence; Triazoles; Voriconazole

2009
Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:1

    Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Male; Meningitis, Cryptococcal; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2009
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole

2009
Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010, Volume: 14, Issue:4

    Topics: Adult; Antifungal Agents; Cryptococcus neoformans; Drug Interactions; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Meningitis, Cryptococcal; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2010
[Cryptococcal meningitis with a fatal outcome in an immunocompetent adult].
    Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Headache; Hearing Loss, Bilateral; Humans; Immunocompetence; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Spinal Puncture; Triazoles; Voriconazole

2010
Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir.
    Medical mycology, 2010, Volume: 48, Issue:3

    Topics: Anti-HIV Agents; Antifungal Agents; Cerebrospinal Fluid; Dideoxynucleosides; Drug Monitoring; HIV Infections; Humans; Interferon-gamma; Lamivudine; Male; Meningitis, Cryptococcal; Pyrimidines; Ritonavir; Serum; Triazoles; Voriconazole; Young Adult

2010
[Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient].
    Brain and nerve = Shinkei kenkyu no shinpo, 2010, Volume: 62, Issue:12

    Topics: Administration, Oral; Aged, 80 and over; Amphotericin B; Antigens, Fungal; Cerebrospinal Fluid; Cryptococcus neoformans; Drug Therapy, Combination; Female; Humans; Liposomes; Meningitis, Cryptococcal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
Voriconazole: may be an option for treatment of cryptococcal meningitis.
    Medical mycology, 2011, Volume: 49, Issue:3

    Topics: Animals; Antifungal Agents; Humans; Infant, Newborn; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole

2011
Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Injections, Spinal; Male; Meningitis, Cryptococcal; Mice; Pyrimidines; Triazoles; Voriconazole

2012
Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Microbial Sensitivity Tests; Organophosphates; Pyrimidines; Triazoles; Voriconazole

2012
[Intraventricular cryptococcoma successfully treated with liposomal amphotericin B and voriconazole: a case report].
    No shinkei geka. Neurological surgery, 2012, Volume: 40, Issue:9

    Topics: Amphotericin B; Humans; Liposomes; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole

2012
Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ.
    Diagnostic microbiology and infectious disease, 2012, Volume: 74, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; HIV Infections; Humans; Interferon-gamma; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2012
Two rare cases of central nervous system opportunistic mycoses.
    Arhiv za higijenu rada i toksikologiju, 2012, Volume: 63, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus nidulans; Cryptococcus neoformans; Female; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Neuroaspergillosis; Opportunistic Infections; Pregnancy; Pregnancy Complications, Infectious; Rare Diseases; Treatment Outcome; Voriconazole

2012
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.
    Mycopathologia, 2004, Volume: 158, Issue:2

    Topics: Antifungal Agents; Brain Abscess; Chronic Disease; Cryptococcus neoformans; Fluconazole; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Renal Insufficiency; Time Factors; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole

2004
Voriconazole in an infant with cryptococcal meningitis.
    Chinese medical journal, 2008, Feb-05, Volume: 121, Issue:3

    Topics: Antifungal Agents; Humans; Infant; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole

2008
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    AIDS (London, England), 2001, Nov-23, Volume: 15, Issue:17

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole

2001